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In human cytogenetics, the terms “mosaicism”
and “chimerism” indicate subjects with cells of two
or more chromosomally distinct kinds. A chimera
is an individual with a mixture of genotypes from
two zygotes. Chimeras arise from rare instances of
products of two separate acts of syngamy in one
ovum or from infrequent cases of intermixture or
exchange of cells between individuals of different
zygotic origins.1 In mosaicism, two or more cell
lines come from the same zygote as a result of non-
disjunction during mitotic division.2 Chimerism
can be distinguished from mosaicism with genetic
analysis in certain circumstances. 
Here, we report the diagnosis of a chimeric
fetus with mosaic Down syndrome in a twin
pregnancy.
Case Report
tA 36-year-old, gravida 2, para 1, twin-pregnan
 woman was referred at 20 weeks’ gestation
because of identification of chromosomal ab-
normality (47,XX,+21[5]/46,XX[15]) by in situ
culture of amniotic fluid of one fetus (twin
A) in a twin pregnancy. The karyotype of the co-
twin (twin B) was 46,XY. The husband was
38 years old. The couple was nonconsanguine-
y ous and healthy, without remarkable famil
yhistory. Their first child was a 2-year-old health
boy. This pregnancy resulted from clomiphene
 citrate usage and artificial insemination with
y the husband’s semen because of secondar
infertility.
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Prenatal diagnosis of simultaneous occurrence of chimerism and autosomal mosaicism is extremely rare.
We report the prenatal diagnosis and genetic analysis of a fetus in a twin pregnancy with mosaic
47,XX,+ g21/46,XX with chimeric XX/XY. A 36-year-old, para 1, woman was referred for genetic counselin
at 20 weeks’ gestation because of abnormal karyotype (47,XX,+21/46,XX) in one fetus in a twin pregnancy.
Cordocentesis revealed 47,XX,+ f21[3]/46,XX[35]/46,XY[7] in this fetus. Postnatal cytogenetic analysis o
cord blood confirmed three cell lines in this twin (A) and 46,XY in the co-twin (B). Postmortem patho-
logic findings of both fetuses were normal. Fluorescence in situ hybridization identified three cell lines in
the cord blood of twin A. Molecular genetic analysis using polymorphic DNA markers revealed parental
corigin of fetal tissue, and confirmed the chimeric status. Molecular genetic analysis with polymorphi
DNA markers help to differentiate chimerism from mosaicism and define the origin of cell lines, which
may have importance in genetic counseling. [J Formos Med Assoc 2006;105(8):659–663]
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CASE REPORT
Cordocentesis of twin A showed 47,XX,+21[3]/
46,XX[35]/46,XY[7]. Sonographic findings of
both fetuses were unremarkable. The septum
between the two amniotic bags was quite clear.
The placenta of twin A was over the anterior uter-
ine wall, and that of twin B was over the posterior
wall and there was no visible connection between
the two placentae. No signs of twin-to-twin trans-
fusion syndrome were noted. The parents opted
for termination of the twin pregnancy at the 22nd
gestational week.
The pregnancy was terminated with intra-
venous prostaglandin E2. Twin B was delivered
with its placenta 90 minutes after twin A was deli-
vered with its placenta. Postmortem pathologic ex-
amination showed that both fetuses were grossly
normal without low-set ears or simian crease on
palms and normotrophic for the gestational age
(twin A, body weight 560 g and placental weight
300 g; twin B, body weight 540 g and placental
weight 280 g). Both fetuses had normal gonads,
and neither of the placenta had fibrotic nodules.
Cytogenetic analysis of the placenta of twins
A and B showed 46,XX and 46,XY, respectively. 
The karyotype of the cord blood of twin A was
47,XX,+21[8]/46,XX[75]/46,XY[3] and that of twin
B was 46,XY. Both parents had normal karyotypes.
Fluorescence in situ hybridization (FISH) analy-
sis of the cord blood of twin A using CEP X (spec-
trum orange) and CEP Y (SAT III) (spectrum
green) (Vysis, Downers Grove, IL, USA) on 268
interphase cells revealed that 250 cells (93.3%)
were positive for two X chromosome signals and
18 cells (6.7%) were positive for one X chromo-
some signal and one Y chromosome signal, con-
sistent with the findings of the G-banding study.
FISH analysis of cord blood of twin A with CEP X
(spectrum blue), CEP Y (spectrum gold) and LSI
21 (spectrum green) (Vysis) on 34 interphase
cells revealed that four (11.8%) had two chromo-
some X signals and three chromosome 21 signals,
27 (79.4%) had two chromosome X signals and
three (8.8%) had one chromosome X signal and
one chromosome Y signal. 
For molecular genetic analysis, DNA was iso-
lated from the cord blood, placenta, skin, and liver
of twin A, the cord blood and placenta of twin B,
r and the peripheral blood of the parents. Fo
PCR amplification, we used five pairs of chromo-
some X specific primers, i.e. DXS101 (Xq22.11),
DXS1238 (Xq21.2), DXS1237 (Xq21.2), DXS1236
(Xq21.2), DXS1235 (Xq21.2), one pair of chro-
mosome X and Y specific primer (amelogenin)
tand one pair of chromosome 21 specific shor
tandem repeat (STR) primer, D21S11 (21q21.1)
(AmpFlSTR Profiler Plus and AmpFlSTR Cofiler,
RApplied Biosystems, Foster City, CA, USA). PC
was performed with thermal profiling as in-
structed. DNA fragments were analyzed by an au-
tomated DNA sequencer (ABI PRISM 377, Applied
Biosystems) and Genescan Analysis 2.1 software
(Applied Biosystems). The amount of amplicons
was estimated based on the peak height on the
celectrophoretograms. The Table shows the alleli
distribution of polymorphic DNA markers in both
fetuses and parents. The one-paternal and one-
kmaternal origin of chromosome X as well as wea
Y amelogenin signal in liver tissue were compati-
Able with a 46,XX/46,XY chimeric status of twin 
f(Figure). Genetic analysis of DNA from the skin o
twin A was noninformative.
Discussion
Prenatal diagnosis of a fetus with more than one
Ycell line presents a counseling dilemma. XX/X
chimerism or mosaicism are associated with ab-
normal sexual development.3,4 Mosaic 47,+21/46
cases present as Down syndrome. In this report,
twin A had three different cell lines, which could
have led to mental and sexual developmental 
abnormalities.
There are two possible pathogenic mecha-
tnisms of mosaic trisomy 21 in this fetus. The firs
is that subsequent to the initial nondisjunctional
event giving rise to the 47,XX,+21 genotype,
chromosome 21 is lost in a proportion of the
47,XX,+21 cells, giving rise to a 46,XX cell line.
Disomy/trisomy mosaics involving chromosomes
13, 18, 21 and X start as a trisomic zygote.5,6 The
tsecond possible pathogenic mechanism is tha
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the original fetal karyotype was 46,XX, and the
47,XX,+21 cell line arose from a nondisjunc-
tional event sometime thereafter.
The pathogenic mechanisms resulting in a true
mixture of 46,XX and 46,XY cells in a fetus include
fertilization of an ovum and its first polar body,
fertilization of an ovum and its second polar body,
amalgamation of independent embryos from
independently ovulated and separately fertilized
ova, two identical ova from a parthenogenetic 
division of a haploid ovum fertilized by separate
sperms, and an initial 47,XXY conceptus with
postzygotic loss of one X chromosome in one cell
line and loss of the Y chromosome in another
cell line.4,7–9 Molecular genetic analyses using
polymorphic DNA and STR markers can be used
for the determination of parental origin and de-
tection of fetal aneuploidy.9–11 In this case, these
methods were used to determine the parental
corigin as well as the possible mosaic and chimeri
status of chromosomes X and 21. However, a
noninformative result for the extra copy of chro-
wmosome 21 was obtained due to the relatively lo
cell population of 47,XX,+21 in twin A. The one-
Xpaternal and one-maternal origin of the two 
ychromosomes in twin A excludes the possibilit
that XX/XY mosaicism resulted from one XY zy-
gote with subsequent loss of the Y chromosome
and duplication of the X chromosome in a cell
line, because XX/XY mosaicism from one XY zygote
Xwould have the same parental origin of the two 
chromosomes (Table). Nevertheless, the rare con-
dition of XX/XY mosaicism from a 47,XXY zygote
Yafter the fertilization of 23X oocyte with 24X
Xsperm and simultaneous loss of the paternal 
Ychromosome in one cell line as well as loss of the 
chromosome in another cell line later is also a pos-
sible explanation for the origin of twin A.4 Since
f fGenetic analysis o  a etus with mosaicism and chimerism
J Formos Med Assoc | 2006 • Vol 105 • No 8 661
Table. Genotyping of the fetuses and parents with polymorphic DNA markers specific for chromosomes 2, 3, 4, 5, 7, 8, 11,
12, 13, 16, 18, 21, X and Y
Chromosome Markers
Genotype
Father Mother Twin A (Female) Twin B (Male)
Venous Venous Cord blood Liver Skin Placenta Cord blood Placenta
blood blood
2 TPOX a, a a, b a, a a, a a, a a, a a, a a, a
3 D3S1358 a, b a, a a, a a, a a, a a, a a, a a, a
4 FGA b, b a, b b, b b, b b, b b, b b, b b, b
5 D5S818 a, b b, b b, b b, b b, b b, b a, b a, b
5 CSF1PO b, d a, c c, d c, d c, d c, d c, d c, d
7 D7S820 a, b b, c b, b b, b b, b b, b a, b a, b
8 D8S1179 a, a b, c a, b a, b a, b a, b a, b a, b
11 TH01 a, c b, b b, c b, c b, c b, c a, b a, b
12 vWA a, b a, c a, a a, a a, a a, a a, c a, c
13 D13S317 c, c a, b b, c b, c b, c b, c b, c b, c
16 D16S539 c, d a, b b, d b, d b, d b, d a, c a, c
18 D18S51 a, c b, b b, c b, c b, c b, c b, c b, c
21 D21S11 a, c b, c a, c a, c a, c a, c c, c c, c
X DXS101 a a, a a, a a, a a, a a
DXS1238 a b, c a, b a, b a, b b
DXS1237 b a, b a, b a, b a, b a
DXS1236 b a, a a, b a, b a, b a
DXS1235 b a, c a, b a, b a, b c
Amelogenin + + + + + + + +
Y Amelogenin + − − Weak + − − + +
the 47,XXY cell line was absent, chimerism was
the most likely mechanism for the 46,XX and
46,XY cell intermixture. The results STR analysis of
autosomal chromosomes were noninformative
because the 46,XY cell population was relatively
limited. An early deceased third embryo could be
the origin of the cell line of 47,XX,+21 or 46,XY 
in twin A.12 In this case with dizygotic twins, the
most likely mechanism is the transfer of XY cell
line from twin B to twin A through vascular anas-
tomoses.13–15 In a multifetal pregnancy, rapidly
enlarging embryos may meet in the uterine cavity,
and the blood vessels from each side may anasto-
mose in the connecting part of the chorion, lead-
ing to the injection of either fetus from the other.14
Chimerism may be complete or partial, which
is difficult to differentiate prenatally. Complete
(whole-body) chimerism involves all tissues. Par-
tial chimerism, which occurs by placental exchange
of bone marrow stem cells between dizygotic
twins, involves hematogenous tissue only. Blood
group chimerism in twin and triplet pairs is not a
rare phenomenon, and induces immune toler-
ance.14,15 Complete 46,XX/46,XY chimerism has
fbeen reported in individuals with a wide range o
phenotypes including true hermaphroditism,
tambiguous genitalia, clitoromegaly, prominen
labia majora, fusion of the labia, palpable gonads
in the inguinal areas, hypotrophy of the uterus,
hypospadias, shawl scrotum, inguinal hernia and
phenotypically normal persons.1,3,9,11,13,16 A rare
Ycase of chimerism in a fertile woman with 46,X
karyotype and female phenotype has also been
reported.17 Patients with 46,XX/46,XY chimerism
yconfront psychosocial impacts, possible infertilit
and require surgery to correct abnormal pheno-
types. In twin A, the cell line with Y chromosome
was identified in the cord blood and chromo-
some Y specific DNA marker was detected in the
Yliver. The relatively low percentage of the 46,X
cell line and the possible confinement to the
hematogenous system explain the normal female-
type gonads and external genitalia of twin A.
Clinically, XY/XX mosaicism is an occasional
finding in the culture of amniotic fluid, chorio-
nic villi and cord blood. When the fetus is male
by ultrasound examination and the XX cells are
from one colony or a single cultural flask, level I
pseudomosaicism is diagnosed and maternal
tcell contamination is usually impressed withou
further evaluation.18,19 However, chimerism can-
not be completely ruled out without further mole-
rcular analysis. This case alerts us to the need fo
rgreater consideration of the origin of the mino
cell population of XX found in prenatal diag-
gnosis and its consequences. Genetic counselin
should be more comprehensive and further mole-
f cular genetic analysis to define the origins o
co-existing XX and XY cells should be performed
if multiple pregnancy is suspected. 
fIn conclusion, simultaneous occurrence o
r mosaicism and chimerism is rare. Molecula
genetic analysis with polymorphic DNA markers
helps to determine the origin of the cell lines,
c which may have clinical importance in geneti
counseling.
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genotype analysis of microsatellite
markers in the father (F), mother (M),
Yand twin A (A). A weak-positive 
amelogenin in the liver tissue of twin
A was noted.
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